Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes

NCT00276393 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Basal insulin

Sponsor

Mayo Clinic